Notice of Public Meeting of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board, 50094 [2019-20575]

Download as PDF 50094 Federal Register / Vol. 84, No. 185 / Tuesday, September 24, 2019 / Notices subparagraph (f)(2) of Rule 19b–4 20 thereunder, because it establishes a due, fee, or other charge imposed by the Exchange. At any time within 60 days of the filing of such proposed rule change, the Commission summarily may temporarily suspend such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes of the Act. If the Commission takes such action, the Commission shall institute proceedings under Section 19(b)(2)(B) 21 of the Act to determine whether the proposed rule change should be approved or disapproved. IV. Solicitation of Comments Interested persons are invited to submit written data, views, and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Comments may be submitted by any of the following methods: khammond on DSKJM1Z7X2PROD with NOTICES Electronic Comments • Use the Commission’s internet comment form (http://www.sec.gov/ rules/sro.shtml); or • Send an email to rule-comments@ sec.gov. Please include File Number SR– NYSE–2019–50 on the subject line. Paper Comments • Send paper comments in triplicate to: Secretary, Securities and Exchange Commission, 100 F Street NE, Washington, DC 20549–1090. All submissions should refer to File Number SR–NYSE–2019–50. This file number should be included on the subject line if email is used. To help the Commission process and review your comments more efficiently, please use only one method. The Commission will post all comments on the Commission’s internet website (http://www.sec.gov/ rules/sro.shtml). Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for website viewing and printing in the Commission’s Public Reference Room, 100 F Street NE, 20 17 21 15 CFR 240.19b–4(f)(2). U.S.C. 78s(b)(2)(B). VerDate Sep<11>2014 17:37 Sep 23, 2019 Washington, DC 20549 on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of the filing also will be available for inspection and copying at the principal office of the Exchange. All comments received will be posted without change. Persons submitting comments are cautioned that we do not redact or edit personal identifying information from comment submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File Number SR–NYSE–2019–50 and should be submitted on or before October 15, 2019. For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.22 Jill M. Petersen, Assistant Secretary. [FR Doc. 2019–20574 Filed 9–23–19; 8:45 am] BILLING CODE 8011–01–P DEPARTMENT OF STATE [Public Notice 10897] Notice of Public Meeting of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board In accordance with the Federal Advisory Committee Act (FACA), the PEPFAR Scientific Advisory Board (hereinafter referred to as ‘‘the Board’’) will meet on Wednesday, October 16, 2019 at the offices of the U.S. Global AIDS Coordinator and Health Diplomacy located at 1800 G St. NW, Suite 10–300, Washington, DC 20006. The meeting is expected to run from 8:30 a.m. until 5:30 p.m. and is open to the public. The Board is established under the general authority of the Secretary of State and the Department of State (‘‘the Department’’) as set forth in Title 22 of the United States Code, in particular Section 2656 of that Title, and consistent with the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix). The meeting will be hosted by U.S. Global AIDS Coordinator, Ambassadorat-Large Deborah Birx, M.D., who leads the coordination and implementation of PEPFAR, and the Board Chair, Dr. Carlos del Rio. The Board serves the U.S. Global AIDS Coordinator in a solely advisory capacity concerning scientific, implementation, and policy issues related to the U.S. response to HIV/AIDS globally. These issues evolve 22 17 Jkt 247001 PO 00000 CFR 200.30–3(a)(12). Frm 00116 Fmt 4703 Sfmt 4703 and are of concern as they influence the priorities and direction of PEPFAR, the content of national and international strategies for program implementation, and the role of PEPFAR in international discourse regarding an appropriate and resourced response and we advance towards epidemic control of HIV/AIDS. Topics for the October 16 meeting will include a report out from an expert working group on the use of HIV recency testing; updates on PEPFAR 2019 programmatic activities; updates on next-generation HIV biomedical prevention; updates on universal test and treat; and a risk/benefit discussion of the transition to dolutegravir based ART regimens. The public may attend this meeting as capacity allows. Admittance to the meeting will be by means of a prearranged clearance list. In order to be placed on the list and, if applicable, to request reasonable accommodation, please register online via the following: https://forms.gle/vrD4HgcbLQ7aiq4p6 no later than Monday, September 30. While the meeting is open to public attendance, the Board will determine procedures for public participation. Requests for reasonable accommodation that are made after 12 p.m. on September 30, 2019 may not be possible to fulfill. For further information about the meeting, please contact Dr. Sara Klucking, Designated Federal Officer for the Board, Office of the U.S. Global AIDS Coordinator and Health Diplomacy at KluckingSR@state.gov. Sara R. Klucking, Acting Director for Research and Science. [FR Doc. 2019–20575 Filed 9–23–19; 8:45 am] BILLING CODE 4710–10–P DEPARTMENT OF STATE [Public Notice: 10901] Certification Pursuant to Section 7041(f)(2) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2019 Pursuant to section 7041 (f)(2) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2019 (Div. F, Pub. L. 116–6) (SFOAA) and Department of State Delegation of Authority 245–2, I hereby certify that all practicable steps have been taken to ensure that mechanisms are in place for monitoring, oversight, and control of funds made available by the SFOAA for assistance for Libya. This certification shall be published in the Federal Register and, along with E:\FR\FM\24SEN1.SGM 24SEN1

Agencies

[Federal Register Volume 84, Number 185 (Tuesday, September 24, 2019)]
[Notices]
[Page 50094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20575]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 10897]


Notice of Public Meeting of the U.S. President's Emergency Plan 
for AIDS Relief (PEPFAR) Scientific Advisory Board

    In accordance with the Federal Advisory Committee Act (FACA), the 
PEPFAR Scientific Advisory Board (hereinafter referred to as ``the 
Board'') will meet on Wednesday, October 16, 2019 at the offices of the 
U.S. Global AIDS Coordinator and Health Diplomacy located at 1800 G St. 
NW, Suite 10-300, Washington, DC 20006. The meeting is expected to run 
from 8:30 a.m. until 5:30 p.m. and is open to the public.
    The Board is established under the general authority of the 
Secretary of State and the Department of State (``the Department'') as 
set forth in Title 22 of the United States Code, in particular Section 
2656 of that Title, and consistent with the Federal Advisory Committee 
Act, as amended (5 U.S.C. Appendix).
    The meeting will be hosted by U.S. Global AIDS Coordinator, 
Ambassador-at-Large Deborah Birx, M.D., who leads the coordination and 
implementation of PEPFAR, and the Board Chair, Dr. Carlos del Rio. The 
Board serves the U.S. Global AIDS Coordinator in a solely advisory 
capacity concerning scientific, implementation, and policy issues 
related to the U.S. response to HIV/AIDS globally. These issues evolve 
and are of concern as they influence the priorities and direction of 
PEPFAR, the content of national and international strategies for 
program implementation, and the role of PEPFAR in international 
discourse regarding an appropriate and resourced response and we 
advance towards epidemic control of HIV/AIDS. Topics for the October 16 
meeting will include a report out from an expert working group on the 
use of HIV recency testing; updates on PEPFAR 2019 programmatic 
activities; updates on next-generation HIV biomedical prevention; 
updates on universal test and treat; and a risk/benefit discussion of 
the transition to dolutegravir based ART regimens.
    The public may attend this meeting as capacity allows. Admittance 
to the meeting will be by means of a pre-arranged clearance list. In 
order to be placed on the list and, if applicable, to request 
reasonable accommodation, please register online via the following: 
https://forms.gle/vrD4HgcbLQ7aiq4p6 no later than Monday, September 30. 
While the meeting is open to public attendance, the Board will 
determine procedures for public participation. Requests for reasonable 
accommodation that are made after 12 p.m. on September 30, 2019 may not 
be possible to fulfill.
    For further information about the meeting, please contact Dr. Sara 
Klucking, Designated Federal Officer for the Board, Office of the U.S. 
Global AIDS Coordinator and Health Diplomacy at [email protected].

Sara R. Klucking,
Acting Director for Research and Science.
[FR Doc. 2019-20575 Filed 9-23-19; 8:45 am]
BILLING CODE 4710-10-P